Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Severe Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Atrovent + Bricanyl or Atrovent + Ventoline

3 daily inhalations of Atrovent mixture to form Bricanyl or Ventolin form during 48 weeks

DRUG

Placebo

1 capsule lactose during 48 weeks

Trial Locations (13)

29609

Service de Pneumologie, Brest

37044

Service de Pneumologie, Tours

38043

Service de Pneumologie, Grenoble

44093

Service de Pneumologie, Nantes

45067

Service de Pneumologie, Orléans

49033

Service de Pneumologie, Angers

51100

Service de Pneumologie, Reims

54511

Service de Pneumologie, Nancy

75004

Service de Pneumologie, Paris

76031

Service de Pneumologie, Rouen

80054

Service de Pneumologie, Amiens

86000

Service de Pneumologie, Poitiers

87042

Service de Pneumologie, Limoges

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT02103374 - Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State | Biotech Hunter | Biotech Hunter